| Literature DB >> 24616228 |
Shanteri Singh1, Jianjun Zhang, Tyler D Huber, Manjula Sunkara, Katherine Hurley, Randal D Goff, Guojun Wang, Wen Zhang, Chunming Liu, Jürgen Rohr, Steven G Van Lanen, Andrew J Morris, Jon S Thorson.
Abstract
A chemoenzymatic platform for the synthesis of S-adenosyl-L-methionine (SAM) analogues compatible with downstream SAM-utilizing enzymes is reported. Forty-four non-native S/Se-alkylated Met analogues were synthesized and applied to probing the substrate specificity of five diverse methionine adenosyltransferases (MATs). Human MAT II was among the most permissive of the MATs analyzed and enabled the chemoenzymatic synthesis of 29 non-native SAM analogues. As a proof of concept for the feasibility of natural product "alkylrandomization", a small set of differentially-alkylated indolocarbazole analogues was generated by using a coupled hMAT2-RebM system (RebM is the sugar C4'-O-methyltransferase that is involved in rebeccamycin biosynthesis). The ability to couple SAM synthesis and utilization in a single vessel circumvents issues associated with the rapid decomposition of SAM analogues and thereby opens the door for the further interrogation of a wide range of SAM utilizing enzymes.Entities:
Keywords: S-adenosylmethionine; alkylrandomization; biocatalysis; enzymes; methionine adenosyltransferase
Mesh:
Substances:
Year: 2014 PMID: 24616228 PMCID: PMC4076696 DOI: 10.1002/anie.201308272
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336